IP Library Granted Patent US 12,157,744
Granted Patent B2
US 12,157,744 · App. 18/469,860 · Granted Dec 3, 2024

Compounds and methods of their manufacturing

Inventors: Jacob Westman (Järlåsa, SE); Catarina Malmberg (Uppsala, SE)
Assignee: DICOT PHARMA AB
C07D493/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,157,744
App. No.
18/469,860
Granted
Dec 3, 2024
Kind
B2
Abstract

The present document is directed to methods for producing therapeutically active limonoids as well as new limonoid-type compounds.

Claims (19)

1. A compound of Formula III

wherein R 1 is a straight branched or cyclic alkyl group with 1 to 6 carbon atoms that is unsubstituted or substituted.

2. The compound according to claim 1 , wherein R 1 is methyl.

3. The compound according to claim 1 , wherein the compound of formula III is obtained by reacting a compound of Formula Ia with a base, of sufficient strength to open the lactone ring, but not to hydrolyze the group R1 to form a carboxylic group, preferably the base is barium hydroxide octahydrate in methanol, to obtain the compound of Formula III

4. A compound of Formula IV

wherein R 1 is a straight, branched or cyclic alkyl group with 1 to 6 carbon atoms that is unsubstituted or substituted.

5. The compound according to claim 4 , wherein R 1 is methyl.

6. The compound according to claim 4 , wherein the compound of Formula IV is obtained by reacting a compound of Formula III with a selectively oxidizing agent, preferably Dess Martin periodinane, to obtain the compound of Formula IV.

7. A monohydrate salt of compound according to Formula V,

wherein R 1 is methyl,

wherein R2′ is a straight, branched or cyclic optionally substituted alkyl group

with 1 to 6 carbon atoms.

8. A compound according to Formula V,

wherein R 1 is a straight, branched or cyclic alkyl group with 1 to 6 carbon atoms that is unsubstituted or substituted with the proviso that R 1 is not hydrogen, methyl or ethyl,

wherein R2′ is a straight, branched or cyclic optionally substituted alkyl group with 1 to 6 carbon atoms.

9. The compound of claim 1 , wherein R 1 is a straight, branched or cyclic alkyl group with 1 to 6 carbon atoms that is unsubstituted.

10. The compound of claim 1 , wherein R 1 is a straight, branched or cyclic alkyl group with 1 to 6 carbon atoms that is substituted with —OH or a halogen.

11. The compound of claim 4 , wherein R 1 is a straight, branched or cyclic alkyl group with 1 to 6 carbon atoms that is unsubstituted.

12. The compound of claim 4 , wherein R 1 is a straight, branched or cyclic alkyl group with 1 to 6 carbon atoms that is substituted with —OH or a halogen.

Assignments (2)
CHANGE OF NAME Recorded Sep 5, 2024
From: DICOT AB
To: DICOT PHARMA AB
Reel/Frame 068848/0972 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2024
From: WESTMAN, JACOB; MALMBERG, CATARINA
To: DICOT AB
Reel/Frame 068439/0357 →
Priority Claims (1)
SE 2251130-7 · Sep 30, 2022 · national
Continuity (1)
Related Publication 20240124480A1 · Apr 18, 2024